Program Summary: Digital health and technology use has changed drastically since the 2020 pandemic. It is important for Allergists to understand how digital health can be utilized in their practices and how it is being utilized in direct-to-consumer business mod...

Program Summary: Epinephrine is the first line therapy to treat anaphylaxis yet remains underused for a variety of reasons, including fear of needle injection or concern for adverse effects. New delivery devices, including sublingual and intranasal epinephrine, may ...